Clinical Trials
35 trialsNCT07428941 2026-02-24
LegitHealth PH
AI Labs Group S.L
Completed
NCT04223570 2025-11-21
Portable Measurement of Protoporphyrin IX in the Skin
Dartmouth-Hitchcock Medical Center
Completed
NCT06648447 2025-07-09
Tir2401
CentroDerm GmbH
Recruiting
NCT06321003 2025-05-23
SYMILIS OCT
University of Palermo
Recruiting
NCT05976048 2025-04-04
Implementation of Actinic Keratosis Guideline Among General Practitioners.
Maastricht University Medical Center
Active not recruiting
NCT05976061 2025-04-04
High- and Low-risk Actinic Keratosis Referrals to Secondary Care
Maastricht University Medical Center
Active not recruiting
NCT05987553 2025-04-04
The Influence of an E-learning Program on Recognition of Actinic Keratosis
Maastricht University Medical Center
Active not recruiting
NCT06014697 2025-04-04
OCT and Invasion in Cutaneous Skin Lesions
Maastricht University Medical Center
Completed
NCT04969419 2025-01-14
Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo
Momentum Data
Completed
NCT04809662 2024-11-07
Comparing Immune Responses to Topical Imiquimod
University of California, Davis
Terminated
NCT05260073 2024-09-20
PROAK
Almirall, S.A.
Completed
NCT04814953 2024-05-09
HRQoL Keratinocyte Carcinomas
University Hospital, Ghent
Unknown
NCT05725213 2024-02-23
ADL-PDT Under Routine Clinical Conditions in Patients With Actinic Keratosis
Galderma Laboratorium GmbH
Completed
NCT03319251 2023-11-14
Biomarker Database Registry for Photodynamic Therapy
The Cleveland Clinic
Completed
NCT04202445 2023-06-09
MIKADO
LEO Pharma
Completed
NCT05481073 2022-11-14
UV Sensor in Patients With Actinic Keratosis
Almirall, S.A.
Completed
NCT00189254 2022-02-07
A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ
Viatris Inc.
Completed
NCT02674048 2021-02-17
SESAME
Galderma R&D
Completed
NCT02090465 2019-12-17
Assessment of Treatment Success and Quality of Life in Patients With Actinic Keratoses Under Therapy With Ingenol Mebutate in a Period of 8 Weeks
LEO Pharma
Completed
NCT02362152 2019-12-13
RAPID-ACT
LEO Pharma
Completed
NCT02421471 2019-12-13
PMS to Evaluate the Safety and Efficacy of Picato® Gel
LEO Pharma
Completed
NCT04024579 2019-10-22
TAKKOH
Infectopharm Arzneimittel GmbH
Completed
NCT00710489 2019-02-15
Potential Research Study Participant Registry
University of California, Davis
Completed
NCT02594436 2019-01-22
PrAKtice
LEO Pharma
Completed
NCT01571336 2016-09-27
Photodynamic Therapy of Actinic Keratoses With Alacare®
photonamic GmbH & Co. KG
Completed
NCT02209012 2016-09-23
Twelve Month Follow-Up of CP0108
DUSA Pharmaceuticals, Inc.
Completed
NCT01806961 2016-08-03
Observational Trial Tolerability and Efficacy of Resiquimod Gel in Patients Treated for Actinic Keratosis.
Spirig Pharma Ltd.
Terminated
NCT00099112 2015-04-30
Effect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin of Healthy Adults With Fitzpatrick Skin Type II
National Cancer Institute (NCI)
Completed
NCT00952783 2015-03-26
A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study
Peplin
Completed
NCT00953732 2015-03-26
A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
Peplin
Completed
NCT00989313 2015-03-26
A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study
Peplin
Completed
NCT01345760 2012-10-16
Expression Levels of RISC and Microprocessor Complex Components in Epithelial Skin Cancer
Ruhr University of Bochum
Completed
NCT00668733 2010-07-20
Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
Graceway Pharmaceuticals, LLC
Completed
NCT01151956 2010-07-01
Imiquimod and Actinic Keratoses: an Observational Study
Federal University Teaching Hospital, Feldkirch, Austria
Completed
NCT00114023 2007-02-19
1-Year Follow up to the 1473-IMIQ Study
Graceway Pharmaceuticals, LLC
Completed